Terms: = Bone cancer AND STIL, SIL, 6491, ENSG00000123473, Q15468 AND Prognosis
16 results:
1. Aggressive variant of splenic marginal zone lymphoma characterized using a cancer panel test and treated with rituximab-containing chemotherapy: A case report.
Ishiguro K; Sasaki Y; Takagi Y; Niinuma T; Suzuki H; Tokino T; Hayashi T; Takahashi T; Igarashi T; Matsuno Y
Medicine (Baltimore); 2020 Aug; 99(35):e21938. PubMed ID: 32871937
[TBL] [Abstract] [Full Text] [Related]
2. Translocation t(8;14)(q24;q11) with concurrent PTEN alterations and deletions of stil/TAL1 and CDKN2A/B in a pediatric case of acute T-lymphoblastic leukemia: A genetic profile associated with adverse prognosis.
Skalska-Sadowska J; Dawidowska M; Szarzyńska-Zawadzka B; Jarmuż-Szymczak M; Czerwińska-Rybak J; Machowska L; Derwich K
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27759908
[TBL] [Abstract] [Full Text] [Related]
3. Elevated soluble IL-2 receptor levels correlate with tumor bulk of follicular lymphomas with intestinal involvement.
Iwamuro M; Shinagawa K; Okada H; Takata K; Yoshino T; Yamamoto K
Clin Biochem; 2014 Feb; 47(3):191-5. PubMed ID: 24362271
[TBL] [Abstract] [Full Text] [Related]
4. Biologic markers of chronic GVHD.
Pidala J; Sarwal M; Roedder S; Lee SJ
Bone Marrow Transplant; 2014 Mar; 49(3):324-31. PubMed ID: 23872737
[TBL] [Abstract] [Full Text] [Related]
5. Novel and simple prognostic index for nasal natural killer/T-cell lymphoma.
Hanakawa H; Orita Y; Sato Y; Takao S; Marunaka H; Morishita T; Yamashita Y; Hori Y; Domae S; Inokuchi I; Akagi S; Kondo E; Iwaki N; Motomiya K; Okumura H; Yoshino T; Nishizaki K
Head Neck; 2014 Apr; 36(4):551-6. PubMed ID: 23780926
[TBL] [Abstract] [Full Text] [Related]
6. Primary hepatic peripheral T-cell lymphoma treated with corticosteroid.
Miyashita K; Tomita N; Oshiro H; Matsumoto C; Nakajima Y; Ito S; Matsumoto K; Fujita H; Ishigatsubo Y
Intern Med; 2011; 50(6):617-20. PubMed ID: 21422689
[TBL] [Abstract] [Full Text] [Related]
7. [A case of nasal NK/T cell lymphoma presenting with bilateral giant adrenal tumors].
Toba A; Tamura Y; Osajima Y; Kinbara Y; Sato M; Yamaga R; Hashimoto R; Mori S; Miyakoshi S; Ota M; Ito H; Araki A
Nihon Ronen Igakkai Zasshi; 2008 Nov; 45(6):660-5. PubMed ID: 19179800
[TBL] [Abstract] [Full Text] [Related]
8. Interleukin-6 and soluble interleukin-6 receptor levels as markers of disease extent and prognosis in neuroblastoma.
Egler RA; Burlingame SM; Nuchtern JG; Russell HV
Clin Cancer Res; 2008 Nov; 14(21):7028-34. PubMed ID: 18980999
[TBL] [Abstract] [Full Text] [Related]
9. Serum soluble interleukin 2 receptor alpha in human cancer of adults and children: a review.
Bien E; Balcerska A
Biomarkers; 2008 Feb; 13(1):1-26. PubMed ID: 17906988
[TBL] [Abstract] [Full Text] [Related]
10. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract] [Full Text] [Related]
11. Cytokine serum levels in soft tissue sarcoma patients: correlations with clinico-pathological features and prognosis.
Rutkowski P; Kaminska J; Kowalska M; Ruka W; Steffen J
Int J Cancer; 2002 Aug; 100(4):463-71. PubMed ID: 12115531
[TBL] [Abstract] [Full Text] [Related]
12. Alterations of routine blood tests in adult patients with soft tissue sarcomas: relationships to cytokine serum levels and prognostic significance.
Ruka W; Rutkowski P; Kaminska J; Rysinska A; Steffen J
Ann Oncol; 2001 Oct; 12(10):1423-32. PubMed ID: 11762815
[TBL] [Abstract] [Full Text] [Related]
13. Serum adhesion molecules and interleukin-2 receptor as markers of tumour load and prognosis in advanced cutaneous melanoma.
Vuoristo MS; Laine S; Huhtala H; Parvinen LM; Hahka-Kemppinen M; Korpela M; Kumpulainen E; Kellokumpu-Lehtinen P
Eur J Cancer; 2001 Sep; 37(13):1629-34. PubMed ID: 11527688
[TBL] [Abstract] [Full Text] [Related]
14. [Clinical study of infection associated hemophagocytic syndrome].
Shiraishi K; Tanaka K; Okubo Y; Sakamoto A; Jojima H; Fukahori S; Fujimatsu Y; Shiraishi T; Honda J; Oizumi K
Kansenshogaku Zasshi; 2000 Aug; 74(8):630-7. PubMed ID: 11019510
[TBL] [Abstract] [Full Text] [Related]
15. Langerhans cell histiocytosis in children: does soluble interleukin-2-receptor correlate with both disease extent and activity?
Schultz C; Klouche M; Friedrichsdorf S; Richter N; Kroehnert B; Bucsky P
Med Pediatr Oncol; 1998 Aug; 31(2):61-5. PubMed ID: 9680928
[TBL] [Abstract] [Full Text] [Related]
16. Clinical relevance of serum soluble interleukin-2 receptor levels in acute and chronic graft-versus-host disease.
Kobayashi S; Imamura M; Hashino S; Tanaka J; Asaka M
Leuk Lymphoma; 1997 Dec; 28(1-2):159-69. PubMed ID: 9498715
[TBL] [Abstract] [Full Text] [Related]
